GLP-1s are a substantial and growing driver of health plan cost Nearly 840% cost increase: Allowed PMPMs rose from $2.41 to $22.59, an almost 840% per member per month (PMPM) increase, from 2022 to 2024 for employers covering GLP-1s for weight management
The continuous, low-grade viral replication drives a perpetual state of neuro-inflammation, which manifests clinically as the severe brain fog, unrefreshing sleep, and post-exertional malaise (PEM) that define ME/CFS and Long COVID
Roughly 70% of your immune system resides in your gut-associated lymphoid tissue (GALT), making intestinal health inseparable from immune function
Birth control and sexual health Nurx initially began as a service offering online birth control and sexual health, and its still what theyre most known for
Unlike semaglutide, tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways simultaneously